Taming killer cells may halt diabetes progression

Research output: Contribution to journalDebate/Note/Editorial

Abstract

Preclinical studies in mice suggest that the natural killer cell receptor NKp46 may be a new molecular target for delaying the progression of type 1 diabetes by interfering with unexpected natural killer cell-mediated recognition of pancreatic beta cells.

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Endocrinology and Diabetes
Original languageEnglish
Pages (from-to)111-112
JournalNature Immunology
Volume11
Issue number2
Publication statusPublished - 2010
Publication categoryResearch
Peer-reviewedNo